Innerscope Hearing Technologies (Innerscope Hearing Technologies) EBIT : $-3.85 Mil (TTM As of Dec. 2020)

View and export this data going back to 2017. Start your Free Trial

What is Innerscope Hearing Technologies EBIT?

Innerscope Hearing Technologies's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2020 was $-0.62 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.85 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Innerscope Hearing Technologies's annualized ROC % for the quarter that ended in Dec. 2020 was -5.75%. Innerscope Hearing Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -434.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Innerscope Hearing Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -52.45%.

Innerscope Hearing Technologies EBIT Historical Data

The historical data trend for Innerscope Hearing Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innerscope Hearing Technologies EBIT Chart

Innerscope Hearing Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EBIT

Get a 7-Day Free Trial

0.11

-1.84

-3.32

-4.58

-3.24

Innerscope Hearing Technologies Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
EBIT	Get a 7-Day Free Trial															-1.95	-6.07	3.00	-0.17	-0.62

Competitive Comparison of Innerscope Hearing Technologies's EBIT

For the Medical Instruments & Supplies subindustry, Innerscope Hearing Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innerscope Hearing Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innerscope Hearing Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Innerscope Hearing Technologies's EV-to-EBIT falls into.

Innerscope Hearing Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.85 Mil.

Innerscope Hearing Technologies (OTCPK:INND) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Innerscope Hearing Technologies's annualized ROC % for the quarter that ended in Dec. 2020 is calculated as:

	ROC % (Q: Dec. 2020 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2020 )	+	Invested Capital (Q: Dec. 2020 ))	/ count )
=	-0.596 * ( 1 - 0% )	/	( (11.158	+	9.576)	/ 2 )
=	-0.596	/	10.367
=	-5.75 %

where

	Invested Capital		(Q: Sep. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.788	-	2.316	-	( 0.005	-	max(0, 10.715	-	0.029	+	0.005	))
=	11.158

	Invested Capital		(Q: Dec. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.683	-	2.503	-	( 0.003	-	max(0, 10.419	-	0.023	+	0.003	))
=	9.576

Note: The Operating Income data used here is four times the quarterly (Dec. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Innerscope Hearing Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2020 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2020		Q: Dec. 2020
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.492	/	( ( (0.723 + max(-6.902, 0))	+	(0.424 + max(-6.541, 0)) )	/	2 )
=	-2.492	/	( ( 0.723	+	0.424 )	/	2 )
=	-2.492	/	0.5735
=	-434.52 %

where Working Capital is:

	Working Capital		(Q: Sep. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.014	+	0.006	+	0.004)	-	(2.316	+	0.013	+	4.597)
=	-6.902

	Working Capital		(Q: Dec. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.012	+	0.005	+	0.003)	-	(2.503	+	0.011	+	4.047)
=	-6.541

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2020) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Innerscope Hearing Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2020 )
	=	-3.854	/	7.348
	=	-52.45 %

Innerscope Hearing Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Innerscope Hearing Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Innerscope Hearing Technologies (Innerscope Hearing Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innerscope Hearing Technologies Inc (OTCPK:INND) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

2151 Professional Drive, Second Floor, Roseville, CA, USA, 95661

Website

https://www.innd.com

Innerscope Hearing Technologies Inc is a manufacturer and a DTC distributor/retailer of FDA-registered hearing aids, personal sound amplifier products, hearing-related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates audiological and retail hearing device clinics and plans to continue to open and acquire additional clinics. The company operates retail hearing device clinics in California.